Navigation Links
Novavax CEO to Present at BIO Investor Forum 2008
Date:10/28/2008

ROCKVILLE, Md., Oct. 28 /PRNewswire-FirstCall/ -- Novavax, Inc. (Nasdaq: NVAX) a clinical-stage vaccine company, announced today that Dr. Rahul Singhvi, President and Chief Executive Officer, will be presenting at the BIO Investor Forum 2008 at 8:30 am. (PT) on October 30, 2008 at the Palace Hotel in San Francisco, California. Dr. Singhvi will provide an overview of the company's strategy, research and development progress. A link to the live presentation can be accessed via the Company website at http://www.novavax.com. An archive of the presentation will be available one hour after the event on the Novavax website for 90 days.

ABOUT NOVAVAX

Novavax, Inc. (Nasdaq: NVAX) is a clinical stage biotechnology company, creating novel vaccines to address a broad range of infectious diseases worldwide using advanced proprietary virus-like particle (VLP) technology. The Company produces these VLP based, potent, recombinant vaccines utilizing new and efficient manufacturing approaches. Additional information about Novavax is available at http://www.novavax.com and in the Company's various filings with the Securities and Exchange Commission.


'/>"/>
SOURCE Novavax, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Novavax Completes Enrollment of Its Seasonal Influenza VLP Vaccine Phase IIa Clinical Trial
2. Novavax Commences Clinical Testing of its Seasonal Influenza VLP Vaccine Candidate
3. Novavax Announces Closing of $18 Million Registered Direct Offering
4. Novavax Announces Pricing of $18 Million Financing of Common Stock and Warrants
5. Novavax to Join Russell 3000 Index
6. Novavax CEO to Present at Piper Jaffray Europe Conference, London, UK
7. Novavax CEO to Present at FBR Capital Markets 12th Annual Spring Investor Conference
8. Novavax CEO to Present at ACUMENBioFins 5th Annual Global Healthcare Conference
9. Novavax Reports First Quarter 2008 Financial Results
10. Novavax Announces Release Date of 2008 First Quarter Financial Results and Investor Conference Call
11. Novavax Opens Its First U.S. Vaccine Plant
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... ... March 23, 2017 , ... Ellen Matloff, president and CEO ... (CTC) as a 2017 Women of Innovation® finalist. Matloff will be among several ... , The dinner recognizes women accomplished in science, technology, engineering and math (STEM), ...
(Date:3/23/2017)... , March 23, 2017 ... at four equities in the Biotech industry: Sangamo Therapeutics ... Biologics Inc. (NYSE MKT: SYN), and Regulus Therapeutics Inc. ... st , 2017, Credit Suisse upgraded its rating on Pharmaceuticals/Biotechnology ... downloading their free report at: ...
(Date:3/22/2017)... , March 22, 2017  UBM and ... to announce their extended partnership and the third ... headlined by the 21 st Annual MassMEDIC ... taking place May 3-4, 2017. ... Technology Association (ADVAMED) President and CEO, Scott ...
(Date:3/22/2017)... 2017 MarketNewsUpdates.com News Commentary  ... The traditional ways ... pressured as of late due to the rise of the ... a dramatic impact on patient,s quality of life as Biotech ... identifying new forms of opioid formulations that prevent abuse. Biotech ...
Breaking Biology Technology:
(Date:3/2/2017)... Summary This report provides all ... and its partnering interests and activities since 2010. ... The Partnering Deals and Alliance since 2010 report provides ... of the world,s leading life sciences companies. ... ensure inclusion of the most up to date deal ...
(Date:2/28/2017)... -- News solutions for biometrics, bag drop and New ... At ... 16 March, Materna will present its complete end-to-end passenger journey, ... a real benefit for passengers. To accelerate the whole passenger ... point solutions to take passengers through the complete integrated process ...
(Date:2/22/2017)... , Feb. 22, 2017 With ... 2021, ABI Research identifies four technologies that innovative ... to secure significant share in the changing competitive ... and passive authentication.   "Companies can ... comes to security," says Dimitrios Pavlakis , ...
Breaking Biology News(10 mins):